Loading video...

Video Failed to Load

Go Home

The peptide hypocrisy ‘Health’ commerce in full effect Eli Lilly sources some API, active pharmaceutical ingredient From China while lobbying against compounders using Chinese sourced ingredients Then committed $7 billion to acquire a Chinese peptide company JRE #2469

61,157 views • 7 months ago •via X (Twitter)

0 Comments

No comments available

Comments from the original post will appear here

Related Videos